News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
COVID-19 news, articles, and videos can be found from a variety of sources. Some of the most popular sources for up-to-date information include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the US National Institutes of Health (NIH). Many news outlets are also covering the pandemic and providing relevant articles and videos. Popular sources for news and videos about COVID-19 include CNN, The New York Times, and BBC News. Social media platforms such as Twitter and Facebook are also providing information about the pandemic and its latest developments.
As the Trump administration overhauls government health agencies, partisan trust in these agencies on vaccines has shifted and few express confidence in their ability to carry out key tasks. Most adults are confident in the safety of routine vaccines, but the COVID-19 vaccines remain polarizing with many uncertain about false claims regarding mRNA technology.
Surgical face masks help prevent the spread of airborne pathogens and therefore were ubiquitous during the Covid-19 pandemic. Now, a modified mask could also protect a wearer by detecting health conditions, including chronic kidney disease.
This research provides a comprehensive review of aptamer-based strategies that target SARS-CoV-2, offering a promising avenue for blocking the virus. Behind this groundbreaking paper lies a tale of collaboration across borders, and a quest for the most comprehensive aptamer summary ever compiled.
The ancestor of the virus that causes COVID-19 left its point of origin in Western China or Northern Laos just several years before the disease first emerged in humans up to 2,700 kilometers away in Central China, according to a new study by University of California San Diego School of Medicine researchers and their colleagues.
The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of more stringent approval standards, to lead the agency’s vaccines division. Prasad replaces Peter Marks, the longtime leader of the Center for Biologics Evaluation and Research (CBER), who resigned in March after clashing with Health…